Navalign LLC’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
FFM
SP
Navalign LLC's AMGN Position: Q2 2026 in Review
Navalign LLC reduced its Amgen (AMGN) stake by 0.13% in Q2 2026, selling an estimated $9.93K and leaving 22,715 shares worth $8.23M. The position accounts for 1.92% of the portfolio, ranked #17.
Navalign LLC first reported a position in AMGN in Q1 2021 and has held it in 22 quarters since. 1,264 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Navalign LLC held 22,715 shares of Amgen worth $8.23M as of Q2 2026.
- Navalign LLC sold 29 Amgen shares in Q2 2026, an estimated $9.93K.
- Amgen made up 1.92% of Navalign LLC's portfolio in Q2 2026, its #17 holding.
- Navalign LLC first reported a position in Amgen in Q1 2021 and has held it in 22 quarters since.
- 1,264 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Navalign LLC's 13F filing for Q2 2026, filed 28 Jul 2026.